Get started
Fractyl Health, Inc.Fractyl Health, Inc.Fractyl Health, Inc.

Fractyl Health, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsDocumentsIdeasMindsTechnicalsForecastsSeasonals

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪149.38 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.05 USD
Net income (FY)
‪−68.69 M‬ USD
Revenue (FY)
‪93.00 K‬ USD
Shares float
‪108.69 M‬
Beta (1Y)
0.92

Employees


Employees (FY)
107
Revenue / Employee (1Y)
869.16 USD
Net income / Employee (1Y)
‪−642.00 K‬ USD

About Fractyl Health, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Harith Rajagopalan
Website
fractyl.com
Headquarters
Burlington
ISIN
US35168W1036
FIGI
BBG002Y7NH72
Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.

Check out other big names from the same industry as GUTS.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GUTS is 1.12 USD — it has increased by 2.73% in the past 24 hours. Watch Fractyl Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Fractyl Health, Inc. stocks are traded under the ticker GUTS.
GUTS stock has fallen by −1.74% compared to the previous week, the month change is a −15.67% fall, over the last year Fractyl Health, Inc. has showed a −54.49% decrease.
We've gathered analysts' opinions on Fractyl Health, Inc. future price: according to them, GUTS price has a max estimate of 10.00 USD and a min estimate of 5.00 USD. Watch GUTS chart and read a more detailed Fractyl Health, Inc. stock forecast: see what analysts think of Fractyl Health, Inc. and suggest that you do with its stocks.
GUTS reached its all-time high on Feb 2, 2024 with the price of 14.50 USD, and its all-time low was 0.83 USD and was reached on Aug 6, 2025. View more price dynamics on GUTS chart.
See other stocks reaching their highest and lowest prices.
GUTS stock is 17.12% volatile and has beta coefficient of 0.92. Track Fractyl Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Fractyl Health, Inc. there?
Today Fractyl Health, Inc. has the market capitalization of ‪149.38 M‬, it has decreased by −2.65% over the last week.
Yes, you can track Fractyl Health, Inc. financials in yearly and quarterly reports right on TradingView.
Fractyl Health, Inc. is going to release the next earnings report on Apr 6, 2026. Keep track of upcoming events with our Earnings Calendar.
GUTS earnings for the last quarter are −0.71 USD per share, whereas the estimation was −0.32 USD resulting in a −123.51% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about Fractyl Health, Inc. earnings.
Fractyl Health, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
GUTS net income for the last quarter is ‪−45.60 M‬ USD, while the quarter before that showed ‪−27.89 M‬ USD of net income which accounts for −63.52% change. Track more Fractyl Health, Inc. financial stats to get the full picture.
No, GUTS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2025, the company has 107 employees. See our rating of the largest employees — is Fractyl Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Fractyl Health, Inc. EBITDA is ‪−97.67 M‬ USD, and current EBITDA margin is ‪−99.84 K‬%. See more stats in Fractyl Health, Inc. financial statements.
Like other stocks, GUTS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Fractyl Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Fractyl Health, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Fractyl Health, Inc. stock shows the sell signal. See more of Fractyl Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.